✦ LIBER ✦

Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study

✍ Scribed by Kerstin Bendfeldt; Hanspeter Egger; Thomas E. Nichols; Patrick Loetscher; Niklaus Denier; Pascal Kuster; Stefan Traud; Nicole Mueller-Lenke; Yvonne Naegelin; Achim Gass; Ludwig Kappos; Ernst-Wilhelm Radue; Stefan J. Borgwardt

Book ID: 113504867
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 897 KB
Volume: 1325
Category: Article
ISSN: 0006-8993
DOI: 10.1016/j.brainres.2010.02.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gray matter atrophy and disability progr

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis: A 5-year longitudinal study

✍ Dana Horakova; Michael G. Dwyer; Eva Havrdova; Jennifer L. Cox; Ondrej Dolezal; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Effect of disease-modifying therapies on

Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study

✍ Omar Khan; Fen Bao; Megha Shah; Christina Caon; Alexandros Tselis; Ronald Bailey 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 418 KB

The influence of clinical relapses and s

The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing—remitting multiple sclerosis patients

✍ C. Gasperini; C. Pozzilli; S. Bastianello; T. Koudriavtseva; A. Colleluori; E. M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Effect of laquinimod on MRI-monitored di

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ G Comi; A Pulizzi; M Rovaris; O Abramsky; T Arbizu; A Boiko; R Gold; E Havrdova; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB

Effect of open label pulse cyclophospham

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing–remitting multiple sclerosis

✍ Maria Ida Gobbini; Mary E Smith; Nancy D Richert; Joseph A Frank; Henry F McFarl 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB